Guidelines from Experts on the Strategic Use of Isotretinoin for Optimal Acne Management: Recommendations from the ERAISE ACNE Consensus - Scorecard - MDSpire
Clinical Scorecard: Guidelines from Experts on the Strategic Use of Isotretinoin for Optimal Acne Management: Recommendations from the ERAISE ACNE Consensus
At a Glance
Category
Detail
Condition
Acne vulgaris
Key Mechanisms
Follicular hyperkeratinization, increased sebum production, C. acnes proliferation, inflammation.
Target Population
Adults and adolescents with severe conglobate, nodulocystic, and severe papulopustular acne.
Care Setting
Dermatology clinics in regions with similar patient settings to India.
Key Highlights
Isotretinoin is the gold standard for severe acne management.
Early initiation after failure of first-line therapy is recommended.
Risk-adapted laboratory monitoring is emphasized.
Conventional dosing of 0.5–1 mg/kg/day is preferred for severe cases.
Procedures like comedone extraction and chemical peels can be used during therapy.
Guideline-Based Recommendations
Diagnosis
Diagnosis based on severity and risk factors.
Management
Isotretinoin recommended for severe, scarring, or treatment-refractory acne.
Monitoring & Follow-up
Risk-adapted laboratory monitoring rather than universal protocols.
Risks
Concerns include teratogenicity, mucocutaneous side effects, dyslipidemia, and hepatotoxicity.
Patient & Prescribing Data
Patients with severe acne and select moderate cases.
Isotretinoin can improve quality of life and reduce scarring.
Clinical Best Practices
Educate patients on adherence and avoidance of lesion manipulation.
Incorporate adjuvant care such as gentle cleansers and non-comedogenic moisturizers.
